| Authors: |
Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. GCIssa@mdanderson.org., Larson RA; University of Chicago, Chicago, IL., Hughes TP; South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, SA., Hochhaus A; Hematology and Medical Oncology, Universitätsklinikum Jena, Jena., Takahashi N; Department of Hematology, Akita University, Akita City., Bombaci F; CML Patients Group, CML Advocates Network, Turin., Wang J; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin., Kim DW; Ujieongbu Eulji Medical Center, Geumo-dong, Uijeongbu-si., Kim DDH; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON., Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Masaryk University, Brno, Czech Republic., Goh YT; Department of Hematology, Singapore General Hospital., Le Coutre P; Department of Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin., Kim I; Department of Internal Medicine, Seoul National University Hospital, Biomedical Research Institute, Cancer Research Institute, Seoul National University College of Medicine, Seoul., Etienne G; Hematology Department, Institut Bergonié, Bordeaux., Andorsky D; Sarah Cannon Research Institute at Rocky Mountain Cancer Centers, Boulder, CO., Gu E; Novartis Pharmaceuticals Corporation, Cambridge, MA., Zhang Y; Novartis Pharmaceuticals Corporation, East Hanover, NJ., McCulloch T; Novartis Pharmaceuticals Corporation, Basel., Agrawal N; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Jinwal R; Novartis Healthcare Pvt. Ltd, Hyderabad., Damon A; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Sadek I; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Cortes JE; Georgia Cancer Center, Augusta University, Augusta, GA. |
